Market Trends Toward New Normal in Trinity Industries, Progenics Pharmaceuticals, National CineMedia, Sykes Enterprises, Tennant, and CyberOptics — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Trinity Industries, Inc. TRN, Progenics Pharmaceuticals Inc. PGNX, National CineMedia, Inc. NCMI, Sykes Enterprises, Incorporated SYKE, Tennant Company TNC, and CyberOptics Corporation CYBE, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TRN DOWNLOAD: http://MarketSourceResearch.com/register/?so=TRN

PGNX DOWNLOAD: http://MarketSourceResearch.com/register/?so=PGNX

NCMI DOWNLOAD: http://MarketSourceResearch.com/register/?so=NCMI

SYKE DOWNLOAD: http://MarketSourceResearch.com/register/?so=SYKE

TNC DOWNLOAD: http://MarketSourceResearch.com/register/?so=TNC

CYBE DOWNLOAD: http://MarketSourceResearch.com/register/?so=CYBE

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Trinity Industries, Inc. TRN, Progenics Pharmaceuticals Inc. PGNX, National CineMedia, Inc. NCMI, Sykes Enterprises, Incorporated SYKE, Tennant Company TNC, and CyberOptics Corporation CYBE on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TRINITY INDUSTRIES, INC. (TRN) REPORT OVERVIEW

Trinity Industries' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Trinity Industries reported revenue of -$195.40MM vs -$359.00MM and analysts estimated basic earnings per share $0.20 vs $3.54 (down 94.35%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Trinity Industries reported revenue of $2,509.10MM vs $2,397.40MM (up 4.66%) and analysts estimated basic earnings per share $1.09 vs $4.62 (down 76.41%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $1.63 and is expected to report on February 19th, 2020.

To read the full Trinity Industries, Inc. (TRN) report, download it here: http://MarketSourceResearch.com/register/?so=TRN

-----------------------------------------

PROGENICS PHARMACEUTICALS INC. (PGNX) REPORT OVERVIEW

Progenics Pharmaceuticals' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Progenics Pharmaceuticals reported revenue of $3.24MM vs $3.89MM (down 16.74%) and analysts estimated basic earnings per share -$0.18 vs -$0.04. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Progenics Pharmaceuticals reported revenue of $15.62MM vs $11.70MM (up 33.54%) and analysts estimated basic earnings per share -$0.87 vs -$0.73. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$0.19 and is expected to report on March 12th, 2020.

To read the full Progenics Pharmaceuticals Inc. (PGNX) report, download it here: http://MarketSourceResearch.com/register/?so=PGNX

-----------------------------------------

NATIONAL CINEMEDIA, INC. (NCMI) REPORT OVERVIEW

National CineMedia's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, National CineMedia reported revenue of $137.40MM vs $140.70MM (down 2.35%) and analysts estimated basic earnings per share $0.22 vs $0.61 (down 63.93%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, National CineMedia reported revenue of $441.40MM vs $426.10MM (up 3.59%) and analysts estimated basic earnings per share $0.39 vs $0.89 (down 56.18%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.03. The estimated EPS forecast for the next fiscal year is $0.43 and is expected to report on February 20th, 2020.

To read the full National CineMedia, Inc. (NCMI) report, download it here: http://MarketSourceResearch.com/register/?so=NCMI

-----------------------------------------

SYKES ENTERPRISES, INCORPORATED (SYKE) REPORT OVERVIEW

Sykes Enterprises' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Sykes Enterprises reported revenue of $415.20MM vs $419.25MM (down 0.97%) and basic earnings per share $0.40 vs -$0.41. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Sykes Enterprises reported revenue of $1,625.69MM vs $1,586.01MM (up 2.50%) and analysts estimated basic earnings per share $1.16 vs $0.77 (up 50.65%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.43. The estimated EPS forecast for the next fiscal year is $2.41 and is expected to report on February 24th, 2020.

To read the full Sykes Enterprises, Incorporated (SYKE) report, download it here: http://MarketSourceResearch.com/register/?so=SYKE

-----------------------------------------

TENNANT COMPANY (TNC) REPORT OVERVIEW

Tennant's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Tennant reported revenue of $285.21MM vs $279.30MM (up 2.12%) and analysts estimated basic earnings per share $0.43 vs -$0.18. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Tennant reported revenue of $1,123.51MM vs $1,003.07MM (up 12.01%) and analysts estimated basic earnings per share $1.86 vs -$0.35. Analysts expect earnings to be released on April 22nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $2.79 and is expected to report on February 20th, 2020.

To read the full Tennant Company (TNC) report, download it here: http://MarketSourceResearch.com/register/?so=TNC

-----------------------------------------

CYBEROPTICS CORPORATION (CYBE) REPORT OVERVIEW

CyberOptics' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, CyberOptics reported revenue of $18.06MM vs $13.18MM (up 37.09%) and analysts estimated basic earnings per share $0.16 vs $0.07 (up 128.57%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, CyberOptics reported revenue of $64.72MM vs $53.33MM (up 21.35%) and analysts estimated basic earnings per share $0.40 vs $0.19 (up 110.53%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.02.

To read the full CyberOptics Corporation (CYBE) report, download it here: http://MarketSourceResearch.com/register/?so=CYBE

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Jim Patterson, Media Department

Office: +1 (704) 343-6361

E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.